
Examination of an early podocyte injury biomarker across hypertension stages and its change after nephroprotective therapy in a Central Asian cohort.
Key Takeaways
- Urinary nephrin increased across stages from approximately 92 to 165 ng/mL
- Nephrinuria correlated with systolic blood pressure, aldosterone, eGFR, and RFR
- Nephrinuria decreased 23–32% after six months of nephroprotective treatment
